Trials / Completed
CompletedNCT02932592
evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients (AGREEMENT)
evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 196 (actual)
- Sponsor
- University of Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the glycemic variations during acute coronary syndrome in non-diabetic patients (euglycemic, or with impaired fasting glucose, or with impaired glucose tolerance)
Detailed description
All nondiabetic patients with dysglycemia (fasting plasma glucose between 100 and 125 mg/dl) will be monitored with a device (Continuous Glucose Monitoring System) and all these patients will be undergone an oral glucose tolerance test after the discharge from this Unit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous Glucose Monitoring System (i Pro 2 - Medtronic) | This device can register blood glucose values and excursions. This device consists of a needle (applied in subcutaneous way) and of a recording device. |
Timeline
- Start date
- 2016-03-16
- Primary completion
- 2017-03-25
- Completion
- 2017-10-31
- First posted
- 2016-10-13
- Last updated
- 2022-05-26
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02932592. Inclusion in this directory is not an endorsement.